Immutep IMMP
NASDAQ IMMP
$4.72 +0.01 (+0.21%)
As of: Sep 30, 2026 · 10:16 AM EDT

Immutep (IMMP) Net Margin (2016 - 2017)

Updated

Immutep's Net Margin was -544.79% in the year ended Jun 30, 2026, up 49.85 percentage points from -594.64% a year earlier.

Analysis

Immutep (IMMP) Net Margin (2016 - 2017) Analysis & Trends

From the year ended Jun 30, 2009 onward, Immutep has reported Net Margin for 14 years.

  • Net Margin shows a four-year change of -544.77 percentage points (years ended Jun 2022 to Jun 2026).
  • The figure for the year ended Jun 30, 2026 marks the highest annual Net Margin since the year ended Jun 30, 2022.
  • Per Business Quant data, Net Margin in earlier years was -594.64% in the year ended Jun 30, 2025 and -0.02% in the year ended Jun 30, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 21.86%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 21.27%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -8.04%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 22.61%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 18.81%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 23.62%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -134.51%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -1.65%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 32.99%
10 Immutep 35.63 Mn 35.63 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 -1,114.91%
Mar 31, 2017 -129.02%
Mar 31, 2016 -687.45%
API Access

Immutep Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=IMMP&period=max&api_key=YOUR_API_KEY